5.70
price down icon6.86%   -0.42
after-market Handel nachbörslich: 5.70
loading
Schlusskurs vom Vortag:
$6.12
Offen:
$5.73
24-Stunden-Volumen:
1.30M
Relative Volume:
0.83
Marktkapitalisierung:
$382.44M
Einnahmen:
$217.11M
Nettoeinkommen (Verlust:
$-651.19M
KGV:
-0.4388
EPS:
-12.99
Netto-Cashflow:
$-387.26M
1W Leistung:
-25.97%
1M Leistung:
-30.83%
6M Leistung:
-30.06%
1J Leistung:
-87.72%
1-Tages-Spanne:
Value
$5.52
$5.88
1-Wochen-Bereich:
Value
$5.52
$7.7704
52-Wochen-Spanne:
Value
$5.26
$47.60

Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile

Name
Firmenname
Ginkgo Bioworks Holdings Inc
Name
Telefon
(877) 442-5362
Name
Adresse
27 DRYDOCK AVENUE, BOSTON
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
2024-08-08
Name
Neueste SEC-Einreichungen
Name
DNA's Discussions on Twitter

Vergleichen Sie DNA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
DNA
Ginkgo Bioworks Holdings Inc
5.70 382.44M 217.11M -651.19M -387.26M -12.99
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-15 Herabstufung BTIG Research Neutral → Sell
2024-05-10 Herabstufung William Blair Mkt Perform → Underperform
2023-11-14 Herabstufung Raymond James Outperform → Mkt Perform
2023-11-09 Herabstufung BTIG Research Buy → Neutral
2023-06-02 Herabstufung Goldman Neutral → Sell
2023-05-11 Herabstufung William Blair Outperform → Mkt Perform
2022-11-29 Eingeleitet Berenberg Buy
2022-10-04 Eingeleitet Morgan Stanley Equal-Weight
2022-05-18 Herabstufung BofA Securities Neutral → Underperform
2022-03-02 Fortgesetzt Cowen Outperform
2022-02-23 Eingeleitet Goldman Neutral
2022-02-01 Eingeleitet BofA Securities Neutral
2022-01-28 Eingeleitet BofA Securities Buy
2022-01-07 Eingeleitet BTIG Research Buy
2021-11-29 Eingeleitet Jefferies Buy
2021-10-13 Eingeleitet Raymond James Outperform
2021-10-12 Eingeleitet William Blair Outperform
2021-09-20 Eingeleitet HSBC Securities Buy
Alle ansehen

Ginkgo Bioworks Holdings Inc Aktie (DNA) Neueste Nachrichten

pulisher
Mar 29, 2025

Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know - MSN

Mar 29, 2025
pulisher
Mar 26, 2025

Where are the Opportunities in (DNA) - news.stocktradersdaily.com

Mar 26, 2025
pulisher
Mar 24, 2025

Largest borrow rate increases among liquid names - TipRanks

Mar 24, 2025
pulisher
Mar 22, 2025

Ginkgo Bioworks Holdings, Inc. (DNA) Surpasses Market Returns: Some Facts Worth Knowing - MSN

Mar 22, 2025
pulisher
Mar 16, 2025

(DNA) Technical Pivots with Risk Controls - Stock Traders Daily

Mar 16, 2025
pulisher
Mar 14, 2025

After Plunging -52.33% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA) - Yahoo Finance

Mar 14, 2025
pulisher
Mar 13, 2025

SBI Securities Co. Ltd. Acquires Shares of 2,905 Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World

Mar 13, 2025
pulisher
Mar 08, 2025

Ginkgo Bioworks (DNA) Upgraded to Buy: Here's Why - MSN

Mar 08, 2025
pulisher
Mar 07, 2025

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consort - GuruFocus.com

Mar 07, 2025
pulisher
Mar 07, 2025

Ginkgo Bioworks (DNA) Insider Trading Activity 2025 - MarketBeat

Mar 07, 2025
pulisher
Mar 06, 2025

Ginkgo Bioworks CFO sells shares worth $6,102 - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Ginkgo Bioworks CFO sells shares worth $6,102 By Investing.com - Investing.com Australia

Mar 06, 2025
pulisher
Mar 06, 2025

Ginkgo Bioworks executive sells shares for over $3k - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Y Intercept Hong Kong Ltd Purchases New Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

(DNA) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Mar 05, 2025
pulisher
Mar 04, 2025

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Ginkgo Bioworks Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 18, 2022DNA - ACCESS Newswire

Mar 04, 2025
pulisher
Mar 03, 2025

Global Microbial Fermentation Technology Market to Increase at a Steady Growth Rate of ~5% by 2032 | DelveInsight - GlobeNewswire Inc.

Mar 03, 2025
pulisher
Mar 03, 2025

Global Microbial Fermentation Technology Market to Increase at a Steady Growth Rate of ~5% by 2032 | DelveInsight - GlobeNewswire

Mar 03, 2025
pulisher
Mar 02, 2025

Top 5 Synthetic Biology Public Companies (March 2025) - Securities.io

Mar 02, 2025
pulisher
Mar 01, 2025

These Analysts Think Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) Sales Are Under Threat - Simply Wall St

Mar 01, 2025
pulisher
Mar 01, 2025

Ginkgo Bioworks (DNA) Expected to Announce Earnings on Thursday - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Ginkgo Bioworks (NYSE:DNA) Shares Gap DownHere's What Happened - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Ginkgo Bioworks (NYSE:DNA) Posts Quarterly Earnings Results, Misses Expectations By $0.37 EPS - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Ginkgo Bioworks (NYSE:DNA) Posts Earnings Results - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

DNA; SRNG Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Ginkgo Bioworks Holdings Inc. (f/k/a Soaring Eagle Acquisition Corp.) Investors of Class Action and Deadline: January 18, 2022 - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 27, 2025

Ginkgo Bioworks Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Ginkgo Bioworks Shrinks Office and Lab Footprint in Boston, Cambridge - Connect CRE

Feb 27, 2025
pulisher
Feb 27, 2025

Ginkgo Bioworks: Revenue Struggles Continue - Seeking Alpha

Feb 27, 2025
pulisher
Feb 27, 2025

2025 Is Make Or Break For Ginkgo Bioworks (NYSE:DNA) - Seeking Alpha

Feb 27, 2025
pulisher
Feb 27, 2025

Ginkgo Bioworks Holdings Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance

Feb 27, 2025
pulisher
Feb 26, 2025

Ginkgo Bioworks: Key Takeaways from Q4 and Full-Year 2024 Earnings Report - HPBL

Feb 26, 2025
pulisher
Feb 26, 2025

Cautious Outlook on Ginkgo Bioworks: Sell Rating Amid Financial and Strategic Concerns - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 26, 2025
pulisher
Feb 26, 2025

Ginkgo Bioworks Holdings Inc (DNA) Q4 2024 Earnings Call Highlights: Strategic Restructuring ... By GuruFocus - Investing.com Canada

Feb 26, 2025
pulisher
Feb 26, 2025

Ginkgo Bioworks Holdings, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q4 Loss, Misses Revenue Estimates - MSN

Feb 26, 2025
pulisher
Feb 25, 2025

Ginkgo Bioworks Reports Improved Q4 2024 Results - TipRanks

Feb 25, 2025
pulisher
Feb 25, 2025

Ginkgo subleases part of HQ, looks to address $65M of excess space - The Business Journals

Feb 25, 2025
pulisher
Feb 25, 2025

Ginkgo Bioworks Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 25, 2025
pulisher
Feb 25, 2025

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financ - GuruFocus.com

Feb 25, 2025
pulisher
Feb 25, 2025

Ginkgo Bioworks Holdings, Inc. SEC 10-K Report - TradingView

Feb 25, 2025
pulisher
Feb 25, 2025

Ginkgo Bioworks Holdings, Inc. Q4 Loss Narrows - Nasdaq

Feb 25, 2025
pulisher
Feb 25, 2025

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results - Kilgore News Herald

Feb 25, 2025
pulisher
Feb 24, 2025

Ginkgo Bioworks (DNA) to Release Quarterly Earnings on Tuesday - MarketBeat

Feb 24, 2025
pulisher
Feb 22, 2025

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Ginkgo Bioworks Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 18, 2022 – DNA - ACCESS Newswire

Feb 22, 2025
pulisher
Feb 22, 2025

Ginkgo Bioworks (NYSE:DNA) Trading Down 6.3%What's Next? - MarketBeat

Feb 22, 2025
pulisher
Feb 21, 2025

Volta Labs enhances Ginkgo Bioworks sequencing workflow By Investing.com - Investing.com Canada

Feb 21, 2025
pulisher
Feb 21, 2025

Ginkgo Bioworks Integrates Callisto For Difficult-To-Automate Ngs Processes In Their High-Throughput Lab - Marketscreener.com

Feb 21, 2025
pulisher
Feb 21, 2025

Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab - Marketscreener.com

Feb 21, 2025
pulisher
Feb 21, 2025

Ginkgo Bioworks integrates Callisto for difficult-to-automate NG - GuruFocus.com

Feb 21, 2025
pulisher
Feb 21, 2025

Short Interest in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Rises By 5.4% - MarketBeat

Feb 21, 2025

Finanzdaten der Ginkgo Bioworks Holdings Inc-Aktie (DNA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Kapitalisierung:     |  Volumen (24h):